Cargando…

Enhanced Antitumor Efficacy of PhAc-ALGP-Dox, an Enzyme-Activated Doxorubicin Prodrug, in a Panel of THOP1-Expressing Patient-Derived Xenografts of Soft Tissue Sarcoma

Despite poor response rates and dose-limiting cardiotoxicity, doxorubicin (doxo) remains the standard-of-care for patients with advanced soft tissue sarcoma. We evaluated the efficacy of two tetrapeptidic doxo prodrugs (PhAc-ALGP-Dox or CBR-049 and CBR-050) that are locally activated by enzymes expr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Van Renterghem, Britt, Wozniak, Agnieszka, Tarantola, Ludovica, Casazza, Andrea, Wellens, Jasmien, Nysen, Madita, Vanleeuw, Ulla, Lee, Che-Jui, Reyns, Geert, Sciot, Raf, Kindt, Nele, Schöffski, Patrick
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9025547/ https://www.ncbi.nlm.nih.gov/pubmed/35453612 http://dx.doi.org/10.3390/biomedicines10040862

Ejemplares similares

PhAc-ALGP-Dox, a Novel Anticancer Prodrug with Targeted Activation and Improved Therapeutic Index
por: Casazza, Andrea, et al.
Publicado: (2022)

Assessment of the platelet-derived growth factor receptor alpha antibody olaratumab in a panel of patient-derived soft tissue sarcoma xenografts
por: Cornillie, Jasmien, et al.
Publicado: (2019)

Therapeutic Efficacy Assessment of CK6, a Monoclonal KIT Antibody, in a Panel of Gastrointestinal Stromal Tumor Xenograft Models()()
por: Van Looy, Thomas, et al.
Publicado: (2015)

Pazopanib, a Receptor Tyrosine Kinase Inhibitor, Suppresses Tumor Growth through Angiogenesis in Dedifferentiated Liposarcoma Xenograft Models()()()
por: Li, Haifu, et al.
Publicado: (2014)

Characterization and assessment of the sensitivity and resistance of a newly established human gastrointestinal stromal tumour xenograft model to treatment with tyrosine kinase inhibitors
por: Van Looy, Thomas, et al.
Publicado: (2014)

Enapotamab Vedotin, an AXL-Specific Antibody-Drug Conjugate, Demonstrates Antitumor Efficacy in Patient-Derived Xenograft Models of Soft Tissue Sarcoma
por: Van Renterghem, Britt, et al.
Publicado: (2022)

Establishment of an Academic Tissue Microarray Platform as a Tool for Soft Tissue Sarcoma Research
por: Lee, Che-Jui, et al.
Publicado: (2021)

Plocabulin, a novel tubulin inhibitor, has potent antitumor activity in patient-derived xenograft models of gastrointestinal stromal tumors
por: Wang, Yannick, et al.
Publicado: (2020)

Plocabulin, a Novel Tubulin Inhibitor, Has Potent Antitumour Activity in Patient-Derived Xenograft Models of Soft Tissue Sarcoma
por: Wang, Yannick, et al.
Publicado: (2022)

TPGS2000-DOX Prodrug Micelles for Improving Breast Cancer Therapy
por: Tang, Lan, et al.
Publicado: (2021)

Efficacy of PolyMPC–DOX Prodrugs in 4T1 Tumor-Bearing Mice
por: McRae Page, Samantha, et al.
Publicado: (2014)

Expression of THOP1 and Its Relationship to Prognosis in Non-Small Cell Lung Cancer
por: Qi, Lei, et al.
Publicado: (2014)

Sleep deprivation changes thimet oligopeptidase (THOP1) expression and activity in rat brain
por: Visniauskas, Bruna, et al.
Publicado: (2019)

The Histone H1-Like Protein AlgP Facilitates Even Spacing of Polyphosphate Granules in Pseudomonas aeruginosa
por: Chawla, Ravi, et al.
Publicado: (2022)

Why are PHAC, Health Canada gatekeeping access to NACI?
por: Murray, Terry
Publicado: (2021)

Genome‐scale screening in a rat haploid system identifies Thop1 as a modulator of pluripotency exit
por: Xu, Mei, et al.
Publicado: (2022)

The PHACS SMARTT Study: Assessment of the Safety of In Utero Exposure to Antiretroviral Drugs
por: Van Dyke, Russell B., et al.
Publicado: (2016)

Asymmetric Open-Closed Dimer Mechanism of Polyhydroxyalkanoate Synthase PhaC
por: Chek, Min Fey, et al.
Publicado: (2020)

The construction of the novel magnetic prodrug Fe(3)O(4)@DOX and its antagonistic effects on hepatocarcinoma with low toxicity
por: Li, Jun, et al.
Publicado: (2020)

A novel doxorubicin-glucuronide prodrug DOX-GA3 for tumour-selective chemotherapy: distribution and efficacy in experimental human ovarian cancer
por: Houba, P H J, et al.
Publicado: (2001)

Mixed nanomicelles as potential carriers for systemic delivery of Z-GP-Dox, an FAPα-based doxorubicin prodrug: formulation and pharmacokinetic evaluation
por: Zhang, Yuchen, et al.
Publicado: (2015)

Role of PhaC Type I and Type II Enzymes during PHA Biosynthesis
por: Mezzolla, Valeria, et al.
Publicado: (2018)

MDM2 Amplified Sarcomas: A Literature Review
por: Sciot, Raf
Publicado: (2021)

Effects of pharmaceutically active compounds (PhACs) on fish body and scale shape in natural waters
por: Staszny, Adam, et al.
Publicado: (2021)

Doxing: What Adolescents Look for and Their Intentions
por: Chen, Mengtong, et al.
Publicado: (2019)

Characterization and Homology Modeling of Catalytically Active Recombinant PhaC(Ap) Protein from Arthrospira platensis
por: Duangsri, Chanchanok, et al.
Publicado: (2023)

Structure of polyhydroxyalkanoate (PHA) synthase PhaC from Chromobacterium sp. USM2, producing biodegradable plastics
por: Chek, Min Fey, et al.
Publicado: (2017)

Policy in focus: appeals for climate action, PHAC president steps down, FDA approves first e-cigarette
por: Basky, Greg
Publicado: (2021)

CTL–doxorubicin (DOX)–gold complex nanoparticles (DOX–AuGCs): from synthesis to enhancement of therapeutic effect on liver cancer model
por: Liu, Qiqian, et al.
Publicado: (2020)

Systematic Design and Study of Star-like Polymeric Prodrug Unimolecular Micelles β-CD-P[CL-co-(ACL-g-DOX)-SS-MPEG](21) by DPD Simulations
por: Yang, Zexiong, et al.
Publicado: (2023)

Insights from the docked DoxDA Model with Thiosulphate
por: Ray, Sujay, et al.
Publicado: (2016)

Correction: CTL–doxorubicin (DOX)–gold complex nanoparticles (DOX–AuGCs): from synthesis to enhancement of therapeutic effect on liver cancer model
por: Liu, Qiqian, et al.
Publicado: (2022)

Comparison of four phaC genes from Haloferax mediterranei and their function in different PHBV copolymer biosyntheses in Haloarcula hispanica
por: Han, Jing, et al.
Publicado: (2010)

Recombinant methioninase combined with doxorubicin (DOX) regresses a DOX-resistant synovial sarcoma in a patient-derived orthotopic xenograft (PDOX) mouse model
por: Igarashi, Kentaro, et al.
Publicado: (2018)

Single-Centre Experience of Systemic Treatment with Vincristine, Ifosfamide, and Doxorubicin Alternating with Etoposide, Ifosfamide, and Cisplatin in Adult Patients with Ewing Sarcoma
por: Requilé, Annelies, et al.
Publicado: (2017)

Whole genome amplification approach reveals novel polyhydroxyalkanoate synthases (PhaCs) from Japan Trench and Nankai Trough seawater
por: Foong, Choon Pin, et al.
Publicado: (2014)

Data on partial polyhydroxyalkanoate synthase genes (phaC) mined from Aaptos aaptos marine sponge-associated bacteria metagenome
por: Amelia, Tan Suet May, et al.
Publicado: (2017)

A rare case of atypical/anaplastic meningioma with MDM2 amplification
por: Wylleman, Robbert, et al.
Publicado: (2018)

Community Preferences for the Allocation &Donation of Organs - The PAraDOx Study
por: Howard, Kirsten, et al.
Publicado: (2011)

Rationally Designed Oral DOX Gels for Colon-Specific Administration
por: Li, Jie, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_e4k6io09aq1s8o29cldojfjbkd